Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D002216:Captopril / Q000627:therapeutic use; D002637:Chest Pain / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*; D015179:Colorectal Neoplasms / Q000188:drug therapy; D017023:Coronary Angiography; D004077:Digoxin / Q000627:therapeutic use; D019468:Disease Management; D004452:Echocardiography; D004562:Electrocardiography; D005472:Fluorouracil / Q000009:adverse effects*; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D009566:Nitrates / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000964:Antimetabolites, Antineoplastic; D009566:Nitrates; D004077:Digoxin; D002216:Captopril; D014700:Verapamil; D005472:Fluorouracil